Overview

3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia

Status:
Unknown status

Trial end date:
2015-01-01

Target enrollment:

Participant gender:

Summary

The goal: to evaluate the role of high dose ara-c plus idarubicin and mitoxantrone consolidation followed by maintenance in the setting of high total cumulative anthracyclines dose(720-660 mg/m2).

Phase:

Phase 4

Details

Lead Sponsor:

National Research Center for Hematology, Russia

Treatments:

Cytarabine
Daunorubicin
Idarubicin
Mitoxantrone